NVO finally cleared its oral pill approval—wasn't even on most people's radar anymore. But this is the kind of catalyst that matters. The chart setup from here looks clean for accumulation to play out properly. When you've got real product traction combined with technical positioning like this, it's worth paying attention. The market tends to remember these milestones eventually, and that's usually when things get interesting.